Log In
Print
BCIQ
Print
Print this Print this
 

LiRIS

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionLidocaine-releasing intravesical system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCystitis
Indication DetailsTreat interstitial cystitis; Treat interstitial cystitis/painful bladder syndrome
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$587.5M

$67.5M

$520.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today